Literature DB >> 27618199

Prolonged Corrected QT Interval as a Predictor of Clinical Outcome in Acute Ischemic Stroke.

Milan Hromádka1, Jitka Seidlerová2, Vladimír Rohan3, Jan Baxa4, Jakub Šedivý1, Daniel Rajdl5, Ivan Ulč1, Petr Ševčík3, Jiří Polívka3, Richard Rokyta1.   

Abstract

BACKGROUND: This study aimed to investigate changes of corrected QT (QTc) interval during acute ischemic stroke and its correlation with high-sensitivity troponin I (hsTnI), brain natriuretic peptide (BNP), neurological outcome, and 1-year mortality.
METHODS: We registered electrocardiogram in 69 patients immediately after admission to the intensive care unit and then after 24 and 48 hours. Computed tomography was performed on admission to determine brain infarct size and localization. Neurological outcome was assessed by modified Rankin scale (mRS) at discharge.
RESULTS: Forty-five (65.2%) patients had prolonged QTc at baseline; only 18 (26.1%) patients had prolonged QTc after 48 hours. Baseline QTc was not associated with neurological outcome (P = .27). However, prolonged QTc after 48 hours was associated with worse mRS at discharge (4.5 [4.0-6.0] versus 2.0 [1.0-3.0]; P < .0001). Patients who deceased during hospitalization (n = 7 [10.1%]) as compared with survivors had more frequently prolonged QTc after 48 hours (38.9 versus 0%; P < .0001), higher level of hsTnI (48.4 [36.1-75.0] versus 8.6 [3.4-26.5]; P = .003), and BNP (334 [224-866] versus 109 [30-190]; P = .014). In univariate analysis, 1-year mortality was associated with prolonged QTc after 48 hours, hsTnI, and BNP. In multivariate analysis, only BNP remained to be associated with 1-year mortality (odds ratio 3.41, 95% confidence interval 1.06-11.03).
CONCLUSIONS: QTc interval in patients with acute ischemic stroke is a dynamic parameter. Prolonged QTc after 48 hours, but not baseline QTc, correlated with neurological outcome and 1-year mortality. Patients with prolonged QTc had higher level of hsTnI.
Copyright © 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  QTc interval prolongation; brain natriuretic peptide; high-sensitivity troponin I; ischemic stroke; mortality

Mesh:

Substances:

Year:  2016        PMID: 27618199     DOI: 10.1016/j.jstrokecerebrovasdis.2016.08.005

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.

Authors:  Darae Kim; Ga Yeon Lee; Jin-Oh Choi; Kihyun Kim; Seok Jin Kim; Eun-Seok Jeon
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

2.  QT interval prolongation in patients with acute ischemic stroke: a report in northwest China.

Authors:  Jine Wu; Dilimulati Nizhamuding; Peng Liu; Yongrong Jiang; Hua Qiang; Chaofeng Sun; Chongliang Dai; Yanrong Yin
Journal:  J Int Med Res       Date:  2019-10-15       Impact factor: 1.671

3.  QT Interval Dispersion as a Predictor of Clinical Outcome in Acute Ischemic Stroke.

Authors:  Hefei Tang; Jiayao Sun; Yu Wang; Xu Jie; Yan Ma; Anxin Wang; Yijun Zhang; Xingao Wang; Yongjun Wang
Journal:  Front Neurol       Date:  2021-01-22       Impact factor: 4.003

Review 4.  Cardiac Dysfunction in Neurocritical Care: An Autonomic Perspective.

Authors:  Mohammad S Ibrahim; Bennson Samuel; Wazim Mohamed; Kushak Suchdev
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

5.  Relationship of QTc Interval Prolongation with Acute Ischemic Stroke.

Authors:  Osama Shukir Muhammed Amin; Aso Sabir Sheikhbzeni; Abbas Nariman Siddiq
Journal:  Med Arch       Date:  2020-06

6.  Association of QTc Interval with Risk of Cardiovascular Diseases and Related Vascular Traits: A Prospective and Longitudinal Analysis.

Authors:  Chanjuan Deng; Jingya Niu; Liping Xuan; Wen Zhu; Huajie Dai; Zhiyun Zhao; Mian Li; Jieli Lu; Yu Xu; Yuhong Chen; Weiqing Wang; Guang Ning; Yufang Bi; Min Xu; Tiange Wang
Journal:  Glob Heart       Date:  2020-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.